OZ94jXGAl1BJRrQCMlkUsvnQuT33KIIU7fdQb28NOUo7CjDBVfD4S2tF6KbE

孙玉萍

Click:

The Last Update Time:..

Current position: Home > Scientific Research > Paper Publications

Paper Publications

Sintilimab, a PD-1 Inhibitor, Completely Reversed Rarely Refractory Hypofibrinogenemia in a Gastric Cancer Patient: A Case Report and Review of the Literature
Release Time:2021-10-22| Hits:

Institution:山东大学附属济南市中心医院
Title of Paper:Sintilimab, a PD-1 Inhibitor, Completely Reversed Rarely Refractory Hypofibrinogenemia in a Gastric Cancer Patient: A Case Report and Review of the Literature
Journal:FRONTIERS IN ONCOLOGY
First Author:马淑真
Document Code:E178A60243CB4F42BF15ACEB4D147E6A
Volume:10
Number of Words:4000
Translation or Not:No
Date of Publication:2020-10
Release Time:2021-10-22

Prev One:Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer

Next One:Immunoglobulin-like transcript 4 and human leukocyte antigen-G interaction promotes the progression of human colorectal cancer

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University